Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(23 sites)
United States
University of Arizona, Tucson, Arizona Arkansas Children's Hospital, Little Rock, Arkansas University of California Davis, Sacramento, California Children's National Hospital, Washington D.C., District of Columbia Emory University-Arthur M. Blank Hospital, Atlanta, Georgia Emory University-Scottish Rite Hospital, Atlanta, Georgia Tulane School of Medicine, New Orleans, Louisiana University of Mississippi Medical Center, Jackson, Mississippi Washington University of St. Louis, St Louis, Missouri University of New Mexico, Albuquerque, New Mexico Wake Forest University Health Sciences, Wake Forest, North Carolina Nationwide Children's Hospital, Columbus, Ohio Oregon Health and Science University, Portland, Oregon Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania LeBonheur Children's Hospital, Memphis, Tennessee Vanderbilt University Medical Center, Nashville, Tennessee The University of Texas Southwestern Medical Center, Dallas, Texas Baylor College of Medicine, Houston, Texas Children's Memorial Hermann Hospital, Houston, Texas University of Texas Health Science Center at San Antonio, San Antonio, Texas Primary Children's Hospital, Salt Lake City, Utah University of Washington Harborview, Seattle, Washington Medical College of Wisconsin, Milwaukee, Wisconsin